A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Sleep Apnea

In brief

The main aim is to see if danavorexton can help improve people's breathing in the recovery room after abdominal surgery.

Key facts

Study ID: NCT05814016
Run by: Takeda
People needed: 41
Starts: 2023-05-11
Expected to finish: 2024-09-25
Last updated by the study team: 2025-09-16

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Helen Keller Hospital — Sheffield, Alabama, United States
Mayo Clinic - PPDS - Hospital — Phoenix, Arizona, United States
UCSD — La Jolla, California, United States
Cedars Sinai Medical Hospital — West Hollywood, California, United States
Mayo Clinic Jacksonville - PPDS — Jacksonville, Florida, United States
University of Miami - Leonard M. Miller School of Medicine — Miami, Florida, United States
Medical Research Center - Clinic/Outpatient Facility — Miami, Florida, United States
University of South Florida — Tampa, Florida, United States
Cleveland Clinic Florida — Weston, Florida, United States
Rush University — Chicago, Illinois, United States
University of Louisville - Hospital — Louisville, Kentucky, United States
Brigham and Womens Hospital — Boston, Massachusetts, United States
Inspira Health — Mullica Hill, New Jersey, United States
NYU Langone — Mineola, New York, United States
Stony Brook University Medical Center — Stony Brook, New York, United States
Fairview Hospital — Cleveland, Ohio, United States
Cleveland Clinic Hospital — Cleveland, Ohio, United States
Ohio State University Wexner Medical Center — Columbus, Ohio, United States
The Medical College of Wisconsin, Inc. — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.